Cargando…

Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case–Control Study

BACKGROUND: The diagnostic construct of mild neurocognitive disorders (MNCDs) is substantially congruent with previously proposed criteria for mild cognitive impairment (MCI). MNCD/MCI is associated with neuropsychiatric symptoms (NPS). Previous studies have examined the prevalence of NPS in amnesti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levada, Oleg A., Cherednichenko, Nataliya V., Troyan, Alexandra S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415620/ https://www.ncbi.nlm.nih.gov/pubmed/28522977 http://dx.doi.org/10.3389/fpsyt.2017.00075

Ejemplares similares

Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study
por: Levada, Oleg A., et al.
Publicado: (2016)

The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy
por: Troyan, Alexandra S., et al.
Publicado: (2020)

Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder
por: Levada, Oleg A., et al.
Publicado: (2017)

Poststroke Depression Biomarkers: A Narrative Review
por: Levada, Oleg A., et al.
Publicado: (2018)

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits
por: Wiels, Wietse A., et al.
Publicado: (2021)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022)

NMDA Receptor Activity in Neuropsychiatric Disorders
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
por: Levada, Oleg A., et al.
Publicado: (2020)

Editorial: Neurocognitive deficits in psychiatric disorders
por: Yang, Jie
Publicado: (2023)

The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021)

Mindfulness Awareness Is Associated With a Lower Risk of Anxiety and Depressive Symptoms in Older Adults With Neurocognitive Disorders
por: Lam, Linda Chiu Wa, et al.
Publicado: (2021)

New Challenges and Frontiers in the Research for Neuropsychiatric Disorders
por: Tropea, Daniela
Publicado: (2012)

Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Editorial: Temporal lobe dysfunction in neuropsychiatric disorder
por: Gao, Yujun, et al.
Publicado: (2022)

Sex-Specific Differences in Severity of Depressive Symptoms, Heart Rate Variability, and Neurocognitive Profiles of Depressed Young Adults: Exploring Characteristics for Mild Depression
por: Lim, Jae-A, et al.
Publicado: (2020)

Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms
por: Gostner, Johanna M., et al.
Publicado: (2015)

SPECT findings on neuropsychiatric symptoms caused by nitrous oxide abuse
por: Wang, Li, et al.
Publicado: (2022)

Staging, Neurocognition and Social Functioning in Bipolar Disorder
por: Tatay-Manteiga, Amparo, et al.
Publicado: (2018)

Editorial: Early detection and management of neurocognitive disorders
por: Bishnoi, Ram J.
Publicado: (2023)

Multimodal Neuroimaging-Informed Clinical Applications in Neuropsychiatric Disorders
por: O’Halloran, Rafael, et al.
Publicado: (2016)

Editorial: Emotional Disturbance and Brain Imaging in Neuropsychiatric Disorders
por: Esposito, Roberto, et al.
Publicado: (2021)

Editorial: Epidemiology and clinical researches on neuropsychiatric disorders in aging
por: Xie, Wuxiang, et al.
Publicado: (2023)

Anosognosia in Early- and Late-Onset Dementia and Its Association With Neuropsychiatric Symptoms
por: Tondelli, Manuela, et al.
Publicado: (2021)

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression
por: Zhang, Min, et al.
Publicado: (2021)

Neuropsychiatric symptoms and altered sleep quality in cerebral small vessel disease
por: Li, Xi, et al.
Publicado: (2022)

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
por: Bergamini, Giorgio, et al.
Publicado: (2022)

A Tripartite Neurocognitive Model of Internet Gaming Disorder
por: Wei, Lei, et al.
Publicado: (2017)

Nationwide Study of Neuropsychiatric Comorbidity and Medicines Use in Children With Autism Spectrum Disorder in Norway
por: Kiselev, Yury, et al.
Publicado: (2020)

Probing the relevance of the accelerated aging mouse line SAMP8 as a model for certain types of neuropsychiatric symptoms in dementia
por: Bergamini, Giorgio, et al.
Publicado: (2023)

Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability
por: Takano, Tomoyuki
Publicado: (2023)

The Oral-Microbiome-Brain Axis and Neuropsychiatric Disorders: An Anthropological Perspective
por: Bowland, Grace B., et al.
Publicado: (2022)

Selected Methods of Therapeutic Interactions With People With Mild Symptoms of Autism Spectrum Disorder
por: Marta, Kopańska, et al.
Publicado: (2022)

Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery
por: Cross, Amy, et al.
Publicado: (2021)

A Case of Neuropsychiatric Systemic Lupus Erythematosus With Hair Loss as the First Diagnostic Symptom
por: He, Xun, et al.
Publicado: (2022)

Yoga on Our Minds: A Systematic Review of Yoga for Neuropsychiatric Disorders
por: Balasubramaniam, Meera, et al.
Publicado: (2013)

Radiation Risk Analysis of Neuropsychiatric Disorders in Ukrainian Chornobyl Catastrophe Liquidators
por: Loganovsky, Konstantyn N., et al.
Publicado: (2020)

Neuroimaging Insight Into Fragile X-Associated Neuropsychiatric Disorders: Literature Review
por: Elias-Mas, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t41mq551i8h214me38ss9l5ak5